|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Memantine is a clinically well tolerated N - methyl - D - aspartate (NMDA) receptor antagonist : A review of preclinical data 显示文摘 | Parsons CG Danysz W Quack G | 1999 | Neuropharmacology1999，38，6： | 1 |
| 2 | Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptorantagonist,memantine显示文摘 | Popik P Danysz W | 1997 | J Pharmacol Exp Ther1997，280，2： | 1 |
| 3 | Effects of short - acting NMDA receptor, antagonist MRZ 2/576 on morphine tolerance development in mice 显示文摘 | BELOZERTSEVA I V DANYSZ W BESPALOV A Y | 2000 | Naunyn Schmiedbergs Arch Pharmacol2000，361，6： | 1 |
| 4 | 显示文摘 | Irina V. Belozertseva Wojciech Danysz Anton Y. Bespalov | 2000 | Naunyn - Schmiedeberg’s Archives of Pharmacology2000，，6： | 1 |
| 5 | Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-- a review of preclinical data 显示文摘 | Parsons CG Danysz W Quack G | 1999 | Neuropharmacology1999，38，9： | 1 |
| 6 | GlycineB antagonists as potential therapeutic agents显示文摘 | Dr. W. Danysz C. G. Parsons M. Karcz-Kubichal A. Schwaier P. Popik K. Wedzony J. Lazarewicz G. Quack | 1998 | Amino Acids (-)1998，，1： | 1 |
| 7 | Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine:a microdialysis study in rats显示文摘 | Hesselink MB De Boer AG Breimer DD Danysz W | | 0，，09： | 1 |
| 8 | Memantine is a clinically well tolerated N-methyl-D-aspartate ( NMDA ) receptor antagonist: a review of preclinical data显示文摘 | Parsons CG Danysz W Quack G | 1999 | Neuropharmacology1999，38，： | 1 |
| 9 | Memantine is a clinically well tolerated N-methyl-D-aspartate ( NMDA ) receptor antagonist: a review of preclinical data 显示文摘 | Parsons CG Danysz W Quack G | 1999 | Neuropharmacology1999，38，： | 1 |
| 10 | Chronic cerebral hypoperfusion in the rat enhances age-related deficits in spatial memory显示文摘 | SOPALA M DANYSZ W | 2001 | J Neural Transm2001，108，12： | 1 |
| 11 | Memantine is a clinically well tolerated N-methyl-D-aspartate ('NMDA) receptor antagonist--a review of preclinical data 显示文摘 | Parsons CG Danysz W Quack G | 1999 | Neuropharmacology1999，38，18： | 1 |
| 12 | Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal longterm potentiation,short-term exploratory modulation and spatial memory in awake,freely moving rats显示文摘 | Barnes CA Danysz W Parsons CG | 1996 | Eur JNeurosci1996，8，： | 1 |
| 13 | Effects of short-acting NMDA receptor, antagonist MRI 2/576 on morphine tolerance development in mice显示文摘 | Belozertseva TV Danysz W Bespalov AY | 2000 | Naunyn Schmiedberge Arch Pharmacol2000，361，2： | 1 |
| 14 | Neuroprotection of acetyl-cholinergic basal forebrain neurons by memantine and neurokinin B显示文摘 | Wenk GL Zajaczkowski W Danysz W | 1997 | Behav Brain Res1997，83，： | 1 |
| 15 | Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders显示文摘 | Bisaga A Popik P Bespalov AY Danysz W | 2000 | Expert Opin Investig Drugs2000，9，10： | 1 |
| 16 | Alzheimer’s disease,β-amyloid,glutamate,NMDA receptors,and memantine-searching for the connections显示文摘 | Danysz W Parsons C G | 2012 | British J Pharmacology2012，167，： | 1 |
| 17 | Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine-searching for the connections 显示文摘 | Danysz W Parsons CG | 2012 | Br J Pharmacol2012，167，： | 1 |
| 18 | Effect of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation , short-term exploratory modulation and spatial memory in awake , freely moving rats 显示文摘 | Barnes CA Danysz W Parsons CG | 1996 | Eur J Neurosci1996，8，： | 1 |
| 19 | Alzheimer's disease, 15-amyloid, glutamate, NMDA receptors and memantine: searching for the connections显示文摘 | Danysz W Parsons CG | 2012 | Br J Pharmacol2012，167，2： | 1 |
| 20 | Alzheimer's disease, -amyloid, glutamate, NMDA receptors and memantine: searching for the connections显示文摘 | Danysz W Parsons CG | 2012 | Br J Pharmacol2012，167，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员